target audience: TECH BUYER  Publication date: Sep 2023 - Document type: IDC MarketScape - Doc  Document number: # US51186723

IDC MarketScape: Worldwide Life Science R&D RWE, RWD, Platforms, Technologies, and Consulting Services 2023 Vendor Assessment

By:  Nimita Limaye Loading


Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.

Related Links


This IDC Health Insights study has a specific focus on real-world evidence, real-world data, platforms, technologies, and consulting services in the life science industry. This document is a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of an RWD/RWE technology solution provider. This is the first time that an IDC MarketScape assessment on this topic in life sciences has been performed.

"The pharma industry is aggressively building modernized data estates of complex diverse data sets, leveraging technologies for the ingestion, integration, transformation, and tokenization of the same, to cull out extremely valuable insights that will shorten development timelines, scale the probability of technical and regulatory success, and improve clinical outcomes. Data is indeed the new gold, and data magnates are ruling this industry," said Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, IDC.


Do you have questions about this document
or available subscriptions?